9
Participants
Start Date
February 24, 2021
Primary Completion Date
August 12, 2021
Study Completion Date
August 12, 2021
BMS-963272
Specified dose on specified days
Placebo matching BMS-963272
Specified dose on specified days
Local Institution, Port Orange
Local Institution, Miami
Floridian Clinical Research, Miami Lakes
Advanced Pharma - Miami, Miami
Local Institution, Boca Raton
RecioMed Clinical Research Network, Boynton Beach
Cullman Clinical Trials, Cullman
Local Institution, Chattanooga
Local Institution, Germantown
Local Institution, Biloxi
Local Institution, Kansas City
Local Institution, Bastrop
Local Institution, San Antonio
Local Institution, San Antonio
Local Institution, McAllen
Local Institution, Edinburg
Pinnacle Clinical Research - Austin, Austin
Local Institution, Chandler
Arizona Liver Health - Tucson, Tucson
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY